- Trials with a EudraCT protocol (181)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
181 result(s) found for: Microbiota.
Displaying page 1 of 10.
EudraCT Number: 2020-000311-71 | Sponsor Protocol Number: APHP180572 | Start Date*: 2022-02-11 |
Sponsor Name:AP-HP/DRCD | ||
Full Title: Pilot study of a new technique of Oral Fecal Transplantation using frozen stool capsules for the maintenance treatment of UC with pediatric onset | ||
Medical condition: ulcerative colitis | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001197-18 | Sponsor Protocol Number: NOR-BGT-14-10665 | Start Date*: 2015-05-20 |
Sponsor Name:Biogen Idec Norway | ||
Full Title: The effect of Tecfidera® (Dimethyl Fumarate) on the gut microbiota as a causal factor for GI associated adverse events. | ||
Medical condition: multiple sclerosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-003433-41 | Sponsor Protocol Number: APHP180583 | Start Date*: 2023-08-30 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: A prospective, multi-center, double blind randomized trial of fecal microbiota transplantation (FMT) delivered by capsule versus placebo in severe irritable bowel syndrome (IBS) - ICEBOAT (Ibs Caps... | |||||||||||||
Medical condition: Adult patients with severe Irritable Bowel Syndrome (IBS) diagnosed | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000673-24 | Sponsor Protocol Number: PHRC_N_2018_BAY | Start Date*: 2021-04-15 |
Sponsor Name:CHU de Clermont-Ferrand | ||
Full Title: Faecal microbiota transplantation for prevention of graft-versus-host sisease after allogeneic stem cell transplantation for haematological malignancies | ||
Medical condition: Patient who underwent Allogeneic hematopoietic stem cell transplantation (allo-HSCT) for various haematological malignancies. Faecal microbiota transplantation (FMT) will be assessed to prevent al... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003704-31 | Sponsor Protocol Number: ARG-16 | Start Date*: 2019-05-17 |
Sponsor Name:Uppsala University | ||
Full Title: Impact on the intestinal microbiota during antibiotic treatment | ||
Medical condition: Impact on the intestinal microbiota during antibiotic treatment | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000953-30 | Sponsor Protocol Number: EPAAC | Start Date*: 2019-07-25 |
Sponsor Name:Uppsala University Hospital | ||
Full Title: Effects of phenoximetylpenicillin, amoxicillin and amoxicillin-clavulanic acid on the gut microbiota of healthy volunteers: a randomized clinical trail | ||
Medical condition: Effects of phenoximetylpenicillin, amoxicillin and amoxicillin-clavulanic acid on the gut microbiota of healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000467-14 | Sponsor Protocol Number: IEO223 | Start Date*: Information not available in EudraCT | |||||||||||||||||||||
Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA | |||||||||||||||||||||||
Full Title: Colorectal cancer, Vitamina D and microbiota: towards new preventive strategies. A double blind Phase II randomized trial, ColoViD | |||||||||||||||||||||||
Medical condition: Colon rectal cancer stage I - III | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000192-27 | Sponsor Protocol Number: GutHeart1 | Start Date*: 2015-03-19 |
Sponsor Name:Oslo University Hospital | ||
Full Title: GutHeart: Targeting Gut microbiota to treat Heart failure | ||
Medical condition: Heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003816-29 | Sponsor Protocol Number: APHP190183 | Start Date*: 2019-12-16 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE -HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Fecal microbiota transplantation in Crohn’s disease as relay after anti-TNF withdrawal | |||||||||||||
Medical condition: Adult patients with Crohn’s disease diagnosed for at least 6 months and healthy volunteers donors | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006814-35 | Sponsor Protocol Number: MoodBugs_Rifaximin | Start Date*: 2022-09-27 |
Sponsor Name:KU Leuven | ||
Full Title: A randomized, triple-blind, placebo-controlled study on the effect of rifaximin on psychobiological functions in healthy men | ||
Medical condition: Experimental study with healthy participants recruited from the general population; no vulnerable individuals or clinical groups will be involved. Our objective is to test whether rifaximin adminis... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004248-39 | Sponsor Protocol Number: PPI-microbiome | Start Date*: 2018-01-04 |
Sponsor Name:TARGID, KU Leuven | ||
Full Title: Effect of Proton Pump Inhibitors on the duodenal microbiome in healthy volunteers | ||
Medical condition: We will assess the effect of Proton Pump Inhibitors (PPI) on the duodenal, oral and fecal microbiota composition in healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001856-51 | Sponsor Protocol Number: 12.007 | Start Date*: 2014-08-26 | |||||||||||
Sponsor Name:Aleksander Krag | |||||||||||||
Full Title: Anti-fibrotic and molecular aspects of rifaximin in alcoholic liver disease: A randomized placebo controlled clinical trial | |||||||||||||
Medical condition: Liver fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001852-41 | Sponsor Protocol Number: GLP1-FMT | Start Date*: 2022-09-06 |
Sponsor Name:Radboud university medical center | ||
Full Title: BetaFIT study: Beta cell imaging after Faecal mIcrobiota Transplantation | ||
Medical condition: Type 1 diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004967-11 | Sponsor Protocol Number: RC17_0021 | Start Date*: 2018-06-26 | |||||||||||
Sponsor Name:CHU Nantes | |||||||||||||
Full Title: Poca | |||||||||||||
Medical condition: Patients operated with an IPAA for Ulcerative Colitis with active recurrent pouchitis, who respond after 4 weeks of an antibiotherapy, will be randomized | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003654-33 | Sponsor Protocol Number: FLORAL-Sb185 | Start Date*: 2016-12-14 | |||||||||||
Sponsor Name:BIOCODEX | |||||||||||||
Full Title: Effects of the probiotic Saccharomyces boulardii CNCM I-745 and the antibiotic Amoxicillin on the gut microbiota of healthy volunteers An open-label, randomized, parallel groups, monocentric study | |||||||||||||
Medical condition: Healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003835-28 | Sponsor Protocol Number: APHP210089 | Start Date*: 2022-02-17 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS | |||||||||||||
Full Title: Prevention of C. difficile infections with oral vancomycin in patients treated for allogeneic hematopoietic stem cell transplantation, a double-blind, randomized, placebo-controlled trial ” VANCALLO | |||||||||||||
Medical condition: Patients hospitalized for an allogeneic hematopoietic stem cell transplant | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003004-24 | Sponsor Protocol Number: 2015-003004-24 | Start Date*: 2015-11-13 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: Faecal microbiota transplantation for relapsing Clostridium difficile infection | |||||||||||||
Medical condition: Relapsing Clostridium difficile infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003655-29 | Sponsor Protocol Number: T216/2016 | Start Date*: 2017-02-23 | |||||||||||
Sponsor Name:Turku University Hospital | |||||||||||||
Full Title: Acute appendicitis and microbiota- etiology and effects of the antimicrobial treatment | |||||||||||||
Medical condition: Acute appendicitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004180-13 | Sponsor Protocol Number: OCARINA | Start Date*: 2021-10-18 | ||||||||||||||||
Sponsor Name:KU Leuven | ||||||||||||||||||
Full Title: The effect of obeticholic acid on gut microbiota, gastric motility, accommodation, gastrointestinal peptide in healthy volunteers | ||||||||||||||||||
Medical condition: The study will focus on the underlying mechanisms of gastrointestinal motility and gut microbiota in healthy subjects. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004208-37 | Sponsor Protocol Number: S63190 | Start Date*: 2020-08-03 |
Sponsor Name:UZ Leuven | ||
Full Title: Drug repurposing - Statins as microbiota modulating agents in ulcerative colitis | ||
Medical condition: There are two population groups, 20 healthy volunteers and at least 165 individuals diagnosed with IBD. Either with remission to mild/moderate active ulcerative colitis or remission to mild Crohn's... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
